En fase 3 -undersøgelse af revaccination i efterfølgende graviditeter med bivalent RSV -vaccine og varighed af beskyttelse af en enkelt dosis
En fase 3 -undersøgelse for at undersøge sikkerheden, tolerabiliteten og immunogeniciteten af revaccinerende gravide deltagere under efterfølgende graviditeter og persistens af immunitet af en enkelt dosis af en bivalent respiratorisk syncytial virus (RSV) vaccine.
This study aims to check how safe and well-tolerated a second dose of RSVpreF is when given during later pregnancies, and to see how long the immunity lasts from a single dose given during a previous pregnancy by examining the blood of nonpregnant participants who had the vaccine before.
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Detaljeret beskrivelse
This study will include pregnant participants and their unborn babies (Cohort 1 and Cohort 2) and non-pregnant participants (Cohort 3), as described below:
- Cohort 1- Pregnant participants who had previously received RSVpreF as part of a Pfizer clinical trial and have antibody data available from that trial will get a second dose of RSVpreF.
- Cohort 2- Pregnant participants who received the RSVpreF in a previous pregnancy, either through commercial means with Abrysvo® or as part of a Pfizer clinical trial, will be randomly chosen to get either one dose of the RSVpreF or one dose of a placebo. This applies to those who do not have antibody data available from the earlier trial.
For both groups of pregnant participants, the study will look at how safe and well-tolerated the vaccine is during pregnancy, as well as how the body responds to it.
Infants will be monitored for six months after birth to check safety and antibodies level.
• Cohort 3- Nonpregnant participants who received RSVpreF during a previous pregnancy as part of an earlier clinical trial will have blood samples taken to see how well their immune response has persisted over time. Participants will not receive any vaccine.
Undersøgelsestype
Undersøgelsestype
Tilmelding (Anslået)
Tilmelding
Fase
Fase
- Fase 3
Kontakter og lokationer
Studiekontakt
Studiekontakt
- Navn: Pfizer CT.gov Call Center
- Telefonnummer: 1-800-718-1021
- E-mail: ClinicalTrials.gov_Inquiries@pfizer.com
Studiesteder
-
-
-
Buenos Aires, Argentina, 1044
- Rekruttering
- Centro de investigación Clínica OSECAC - Sede Jonas Salk
-
Buenos Aires, Argentina, C1428BNF
- Rekruttering
- Equipo Ciencia
-
Salta, Argentina, 4400
- Rekruttering
- Hospital Público Materno Infantil
-
-
Buenos Aires
-
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina, C1426ABP
- Rekruttering
- Fundación Respirar
-
Mar del Plata, Buenos Aires, Argentina, 7600
- Rekruttering
- Clinica Del Niño Y La Madre
-
-
Tucumán Province
-
San Miguel de Tucumán, Tucumán Province, Argentina, 4000
- Rekruttering
- Clínica Mayo de Urgencias Médicas Cruz Blanca S.R.L
-
San Miguel de Tucumán, Tucumán Province, Argentina, 4000
- Rekruttering
- Instituto de Maternidad y Ginecología Nuestra Señora de las Mercedes
-
-
-
-
Alabama
-
Birmingham, Alabama, Forenede Stater, 35233
- Rekruttering
- University of Alabama at Birmingham - School of Medicine
-
Birmingham, Alabama, Forenede Stater, 35233
- Rekruttering
- Children's of Alabama
-
Birmingham, Alabama, Forenede Stater, 35233
- Rekruttering
- Center for Research in Women's Health
-
Birmingham, Alabama, Forenede Stater, 35233
- Rekruttering
- University of Alabama at Birmingham Women & Infants Center
-
Mobile, Alabama, Forenede Stater, 36604
- Rekruttering
- USA Health Strada Patient Care Center
-
Mobile, Alabama, Forenede Stater, 36604
- Rekruttering
- USA Health Children's and Women's Hospital
-
-
Arizona
-
Phoenix, Arizona, Forenede Stater, 85008
- Rekruttering
- Valleywise Health Medical Center
-
Phoenix, Arizona, Forenede Stater, 85004
- Rekruttering
- ClinMed, LLC
-
Phoenix, Arizona, Forenede Stater, 85008
- Rekruttering
- Valleywise Comprehensive Health Center Women's Clinic
-
-
California
-
Los Angeles, California, Forenede Stater, 90095
- Rekruttering
- UCLA
-
Los Angeles, California, Forenede Stater, 90095
- Rekruttering
- Ronald Reagan UCLA Medical Center
-
Los Angeles, California, Forenede Stater, 90095
- Rekruttering
- Ronald Reagan UCLA Medical Center Drug Information Center , Dept. of Pharmaceutical Services (Drug
-
Los Angeles, California, Forenede Stater, 90095
- Rekruttering
- UCLA (outpatient clinic)
-
Los Angeles, California, Forenede Stater, 90095
- Rekruttering
- Ronald Reagan UCLA Medical Center (inpatient hospital)
-
Los Angeles, California, Forenede Stater, 90095
- Rekruttering
- UCLA Clinical and Translational Research Center (research clinic)
-
Palo Alto, California, Forenede Stater, 94304
- Rekruttering
- Stanford University
-
Palo Alto, California, Forenede Stater, 94304
- Rekruttering
- Stanford University Medical Center
-
Palo Alto, California, Forenede Stater, 94304
- Rekruttering
- Lucile Packard Children's Hospital-Labor and Delivery Unit
-
Palo Alto, California, Forenede Stater, 94304
- Rekruttering
- Stanford Obstetrics Clinic
-
-
Colorado
-
Aurora, Colorado, Forenede Stater, 80045
- Rekruttering
- Children's Hospital Colorado
-
Aurora, Colorado, Forenede Stater, 80045
- Rekruttering
- Anschutz Health Sciences Building (AHSB)
-
Aurora, Colorado, Forenede Stater, 80045
- Rekruttering
- CU Research Pharmacy
-
Aurora, Colorado, Forenede Stater, 80045
- Rekruttering
- University of Colorado AO1 UCH
-
Aurora, Colorado, Forenede Stater, 80045
- Rekruttering
- University of Colorado Hospital Inpatient Pavilion
-
Aurora, Colorado, Forenede Stater, 80045
- Rekruttering
- University of Colorado Hospital Outpatient Pavilion
-
Aurora, Colorado, Forenede Stater, 80045
- Rekruttering
- University of Colorado Research II Building
-
-
Florida
-
North Miami Beach, Florida, Forenede Stater, 33162
- Rekruttering
- Citadelle Clinical Research
-
Panama City, Florida, Forenede Stater, 32405
- Rekruttering
- Emerald Coast OBGYN Clinical Research
-
Panama City, Florida, Forenede Stater, 32405
- Rekruttering
- Emerald Coast Pediatrics
-
Panama City, Florida, Forenede Stater, 32405
- Rekruttering
- HCA Florida Gulf Coast Hospital
-
-
Idaho
-
Boise, Idaho, Forenede Stater, 83706
- Rekruttering
- Saint Alphonsus Regional Medical Center
-
Boise, Idaho, Forenede Stater, 83712
- Rekruttering
- St. Luke's Boise Medical Center
-
Boise, Idaho, Forenede Stater, 83702
- Rekruttering
- Advanced Specialty Research
-
Idaho Falls, Idaho, Forenede Stater, 83404
- Rekruttering
- Clinical Research Prime
-
Nampa, Idaho, Forenede Stater, 83687
- Rekruttering
- Saint Alphonsus Medical Center
-
Nampa, Idaho, Forenede Stater, 83687
- Rekruttering
- St. Luke's Nampa Medical Center
-
-
Iowa
-
Ames, Iowa, Forenede Stater, 50010
- Rekruttering
- Mary Greeley Medical Center
-
Ames, Iowa, Forenede Stater, 50010
- Rekruttering
- McFarland Clinic, PC
-
Ames, Iowa, Forenede Stater, 50010
- Rekruttering
- Accellacare - McFarland
-
-
Kansas
-
Kansas City, Kansas, Forenede Stater, 66160
- Rekruttering
- University of Kansas Medical Center
-
Kansas City, Kansas, Forenede Stater, 66160
- Rekruttering
- The University of Kansas Hospital
-
Kansas City, Kansas, Forenede Stater, 66103
- Rekruttering
- The University of Kansas Hospital Investigational Drug Services
-
Kansas City, Kansas, Forenede Stater, 66160
- Rekruttering
- The University of Kansas Medical Center Medical Office Building
-
-
Louisiana
-
New Orleans, Louisiana, Forenede Stater, 70119
- Rekruttering
- Velocity Clinical Research - New Orleans
-
-
Massachusetts
-
Boston, Massachusetts, Forenede Stater, 02118
- Rekruttering
- Boston Medical Center
-
-
Montana
-
Great Falls, Montana, Forenede Stater, 59405
- Rekruttering
- Boeson Research GTF
-
Great Falls, Montana, Forenede Stater, 59405
- Rekruttering
- OBGYN Associates
-
Kalispell, Montana, Forenede Stater, 59901
- Rekruttering
- Heart & Hands Midwifery
-
Missoula, Montana, Forenede Stater, 59804
- Rekruttering
- Boeson Research MSO
-
Missoula, Montana, Forenede Stater, 59804
- Rekruttering
- Origin Health
-
Missoula, Montana, Forenede Stater, 59804
- Rekruttering
- Boeson Research Laboratory
-
-
Nebraska
-
Grand Island, Nebraska, Forenede Stater, 68803
- Rekruttering
- Velocity Clinical Research, Grand Island
-
Norfolk, Nebraska, Forenede Stater, 68701
- Rekruttering
- Velocity Clinical Research, Norfolk
-
-
New Mexico
-
Albuquerque, New Mexico, Forenede Stater, 87109
- Rekruttering
- Lovelace Women's Hospital
-
Albuquerque, New Mexico, Forenede Stater, 87107
- Rekruttering
- Velocity Clinical Research, Albuquerque
-
Albuquerque, New Mexico, Forenede Stater, 87107
- Rekruttering
- Presbyterian Hospital
-
Albuquerque, New Mexico, Forenede Stater, 87107
- Rekruttering
- UNM Hospital
-
-
New York
-
New York, New York, Forenede Stater, 10065
- Rekruttering
- Weill Cornell Medicine-Cornell University/New York Presbyterian Hospital-Alexandra Cohen Hospital for Women and Newborns
-
-
North Carolina
-
Durham, North Carolina, Forenede Stater, 27710
- Rekruttering
- Duke University - Main Hospital and Clinics
-
Durham, North Carolina, Forenede Stater, 27705
- Rekruttering
- Duke University - Main Hospital and Clinics
-
-
Ohio
-
Cincinnati, Ohio, Forenede Stater, 45229
- Rekruttering
- Cincinnati Children's Hospital Medical Center
-
-
South Carolina
-
Greenville, South Carolina, Forenede Stater, 29605
- Rekruttering
- Prisma Health Maternal Fetal Medicine
-
Greenville, South Carolina, Forenede Stater, 29605
- Rekruttering
- Prisma Health OBGYN Center
-
-
Texas
-
Houston, Texas, Forenede Stater, 77024
- Rekruttering
- Memorial Hermann Memorial City Hospital
-
Houston, Texas, Forenede Stater, 77204
- Rekruttering
- The University of Texas Health Science Center at Houston
-
Weatherford, Texas, Forenede Stater, 76086
- Rekruttering
- Medical City Weatherford
-
Weatherford, Texas, Forenede Stater, 76086
- Rekruttering
- Helios Clinical Research - WEA
-
Weatherford, Texas, Forenede Stater, 76086
- Rekruttering
- Weatherford OB/GYN Associates
-
-
Utah
-
Salt Lake City, Utah, Forenede Stater, 84132
- Rekruttering
- University of Utah
-
Salt Lake City, Utah, Forenede Stater, 84112
- Rekruttering
- University of Utah
-
Salt Lake City, Utah, Forenede Stater, 84132
- Rekruttering
- University of Utah Clinical Neuroscience Center
-
Salt Lake City, Utah, Forenede Stater, 84108
- Rekruttering
- University of Utah Obstetrics and Gynecology Research Offices
-
Salt Lake City, Utah, Forenede Stater, 84112
- Rekruttering
- University of Utah Madsen Health Center - Women's Health
-
-
Virginia
-
Norfolk, Virginia, Forenede Stater, 23502
- Rekruttering
- Sentara Leigh Hospital
-
Norfolk, Virginia, Forenede Stater, 23502
- Rekruttering
- The Group For Women - Kempsville Office
-
Norfolk, Virginia, Forenede Stater, 23502
- Rekruttering
- Tidewater Physicians for Women
-
Norfolk, Virginia, Forenede Stater, 23502
- Rekruttering
- WomensCare Center
-
Richmond, Virginia, Forenede Stater, 23226
- Rekruttering
- Clinical Research Partners, LLC
-
Richmond, Virginia, Forenede Stater, 23226
- Rekruttering
- Infusion Solutions, LLC
-
-
Washington
-
Seattle, Washington, Forenede Stater, 98105
- Rekruttering
- Seattle Children's Hospital
-
Seattle, Washington, Forenede Stater, 98195
- Rekruttering
- University of Washington Medical Center - Montlake
-
Seattle, Washington, Forenede Stater, 98101
- Rekruttering
- Seattle Children's Research Institute
-
Seattle, Washington, Forenede Stater, 98133
- Rekruttering
- University of Washington - Northwest
-
-
-
-
Fajara
-
Banjul, Fajara, Gambia, PO Box 273
- Rekruttering
- Medical Research Council Unit
-
-
-
-
Free State
-
Bloemfontein, Free State, Sydafrika, 9301
- Rekruttering
- Josha Research
-
-
Gauteng
-
Johannesburg, Gauteng, Sydafrika, 2001
- Rekruttering
- Wits RHI
-
Johannesburg, Gauteng, Sydafrika, 1864
- Rekruttering
- University of Witwatersrand (WITS) - Vaccines and Infectious Diseases Analytics (VIDA)
-
Pretoria, Gauteng, Sydafrika, 0181
- Rekruttering
- Into Research
-
Pretoria, Gauteng, Sydafrika, 0152
- Rekruttering
- Setshaba Research Centre
-
-
Western Cape
-
Cape Town, Western Cape, Sydafrika, 7700
- Rekruttering
- MRC Unit on Child And Adolescent Health
-
Cape Town, Western Cape, Sydafrika, 7500
- Rekruttering
- Family Clinical Research Unit (Fam-Cru)
-
Cape Town, Western Cape, Sydafrika, 7700
- Rekruttering
- University of Cape Town Lung Institute (Pty) Ltd
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Pregnant Participants-Cohort 1 and Cohort 2 Key Inclusion Criteria
- Women aged 18 to 49 who are pregnant, between 24 and 36 weeks along, and expecting one baby without known risks for complications can participate.
- Had the RSVpreF or Abrysvo vaccine during a previous pregnancy.
- Had an ultrasound scan at 18 weeks or later during their current pregnancy, with no major fetal problems detected.
- Based on their medical history, physical check-up, and the doctor's judgment, they are found suitable to join the study.
- Agrees to let their baby take part in the study and gives their permission.
- Able to sign a consent form, agreeing to follow the rules and conditions of the study.
Key Exclusion Criteria
- Received any approved or experimental RSV vaccine since their previous pregnancy.
- Has a pre-pregnancy body mass index (BMI) over 40 kg/m2.
- History of a severe bad reaction to a vaccine or a serious allergic reaction (like anaphylaxis) to any ingredient in the study vaccine or a similar vaccine.
- Current pregnancy problems or issues at the time of giving consent.
- Previous pregnancy issues or problems at the time of giving consent.
- Women who are breastfeeding at the time of enrollment
Infant Participants
- Proof that the parent(s) or legal guardian(s) has signed and dated a consent form.
- Parent(s) or legal guardian(s) must agree to attend scheduled visits and follow the study plan, including laboratory tests and other procedures.
Nonpregnant Participants-Cohort 3 Key Inclusion Criteria
- Have already received one dose of the RSVpreF vaccine during their previous pregnancy as part of the Pfizer clinical trial, and the results from that time can be used for this study.
- Able to sign a consent form, agreeing to follow the rules and requirements of the study.
Key Exclusion Criteria
- Received any approved or experimental RSV vaccine after participating in the Pfizer clinical trial.
- Taking part in other studies with new drugs within 28 days before giving consent or during the study period.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Forebyggelse
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Firedobbelt
Antal våben
Våben og indgreb
Deltagergruppe / ArmDeltagergruppe / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Placebo komparator: Placebo
|
Single Dose |
|
Eksperimentel: RSVpreF
|
Single Dose |
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Procentdel af gravide deltagere, der rapporterer bivirkninger
Tidsramme: Fra dag 1 til 4 uger efter vaccination
|
Fra dag 1 til 4 uger efter vaccination
|
|
|
Procentdel af gravide deltagere, der rapporterer alvorlige bivirkninger
Tidsramme: Fra dag 1 gennem hele undersøgelsen
|
Fra dag 1 gennem hele undersøgelsen
|
|
|
Hos spædbarnsdeltagere født af gravide deltagere, der modtog en anden dosis af undersøgelsesinterventionen, rapporterede procentdelen af deltagerne bivirkninger.
Tidsramme: Fra fødslen til 1 måned
|
Fra fødslen til 1 måned
|
|
|
Hos spædbørnsdeltagere født af gravide deltagere, der modtog en anden dosis af undersøgelsesinterventionen, rapporterede procentdelen af deltagerne alvorlige bivirkninger og nyligt diagnosticerede medicinske tilstande.
Tidsramme: Fra fødslen til 6 måneders alder.
|
Fra fødslen til 6 måneders alder.
|
|
|
Andel af deltagere, der opnår neutraliserende antistof mod RSV A og RSV B ved fødslen
Tidsramme: Ved fødslen
|
Ved fødslen
|
|
|
Percentage of pregnant participants reporting local reactions
Tidsramme: From Day 1 Through at least Day 7 after Vaccination
|
Pain at the injection site, redness, and swelling |
From Day 1 Through at least Day 7 after Vaccination
|
|
Percentage of pregnant participants reporting systemic events
Tidsramme: From Day 1 Through at least Day 7 after Vaccination
|
Fever, fatigue, headache, vomiting, nausea, diarrhea, muscle pain, and joint pain |
From Day 1 Through at least Day 7 after Vaccination
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Andel af deltagerne, der opnår neutraliserende antistof mod RSV A og RSV B efter 3 måneder og 6 måneder
Tidsramme: Efter 3 måneder og 6 måneder
|
Efter 3 måneder og 6 måneder
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Efterforskere
Efterforskere
- Studieleder: Pfizer CT.gov Call Center, Pfizer
Publikationer og nyttige links
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Studiestart
Primær færdiggørelse (Anslået)
Primær færdiggørelse
Studieafslutning (Anslået)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- C3671059
- C3671059-OPENLABEL; Marguerite (Anden identifikator: Alias Study Number)
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
Pfizer will provide access to individual de-identified participant data and related study documents (e.g. protocol, Statistical Analysis Plan (SAP), Clinical Study Report (CSR)) upon request from qualified researchers, and subject to certain criteria, conditions, and exceptions. Further details on Pfizer's data sharing criteria and process for requesting access can be found at: https://www.pfizer.com/science/clinical_trials/trial_data_and_results/data_requests.
IPD-deling Understøttende informationstype
- STUDY_PROTOCOL
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .